Concepedia
Statistics
Publications
7
Citations
212
H-Index
Active since
2019
Affiliations
Oregon Health & Science University(Current)
City Of Hope National Medical Center
The Ohio State University
Vi Lam is an author at Oregon Health & Science University specializing in oncology, immunoregulation, and immunotherapy.
Publications per year
2019–2023
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma
Taylor Hashiguchi, Nur Bruss, Scott Best et al. · Molecular Cancer Therapeutics · 2019 · 58 citations
Medicine, Cancer Biology, Oncology +15
Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a <i>TP53-</i> and <i>BAX-</i> Dependent Manner
Tingting Liu, Vi Lam, Elana Thieme et al. · Clinical Cancer Research · 2021 · 49 citations · Full text
Medicine, Oncology, Pharmacology +17
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
Scott Best, Vi Lam, Tingting Liu et al. · Leukemia · 2020 · 38 citations · Full text
Life Sciences, Immunology, Oncology +16
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma
Elana Thieme, Tingting Liu, Nur Bruss et al. · Cell Death and Disease · 2022 · 25 citations · Full text
Medicine, Hematology, Pharmacology +17
T Cell–intrinsic Immunomodulatory Effects of TAK-981 (Subasumstat), a SUMO-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia
Vi Lam, Carly Roleder, Tingting Liu et al. · Molecular Cancer Therapeutics · 2023 · 17 citations · Full text
Life Sciences, Immunology, Oncology +17
1–5 of 7